Cytek BioSciences 

$4.37
23
+$0.07+1.63% Tuesday 20:00

統計

當日最高
4.49
當日最低
4.34
52週高點
6.18
52週低點
2.37
成交量
580,860
平均成交量
840,853
市值
558.77M
本益比
-
股息殖利率
-
股息
-

即將到來

財報

13May預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
下一步
-0.34
-0.19
-0.03
0.12
預期EPS
-0.0975
實際EPS
不適用

財務

-3%利潤率
未盈利
2020
2021
2022
2023
2024
400.91M營收
-12.04M淨利

分析師評級

$6.25平均目標價
最高預估為 7.50。
來自過去6個月內的 2 則評分。這不是投資建議。
買入
100%
持有
0%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 CTKB 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Show more...
執行長
Dr. Wenbin Jiang Ph.D.
員工
663
國家
US
ISIN
US23285D1090

上市

0 Comments

分享你的想法

FAQ

Cytek BioSciences 今天的股價是多少?
CTKB 目前價格為 $4.37 USD,過去 24 小時上漲了 +1.63%。在圖表上更密切關注 Cytek BioSciences 股價表現。
Cytek BioSciences 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Cytek BioSciences 的股票以代號 CTKB 進行交易。
Cytek BioSciences 的股價在上漲嗎?
CTKB 股票較上週下跌 -5%,本月下跌 -2.46%,但在過去一年中,Cytek BioSciences 上漲了 +11.48%。
Cytek BioSciences 的市值是多少?
今天 Cytek BioSciences 的市值為 558.77M
Cytek BioSciences 下一次財報日期是什麼時候?
Cytek BioSciences 將於 May 13, 2026 公布下一次財報。
Cytek BioSciences 上一季度的財報如何?
CTKB 上一季度的財報為每股 -0.34 USD,預估為 -0.02 USD,帶來 -1,600% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Cytek BioSciences 去年的營收是多少?
Cytek BioSciences 去年的營收為 400.91MUSD。
Cytek BioSciences 去年的淨利是多少?
CTKB 去年的淨收益為 -12.04MUSD。
Cytek BioSciences 有多少名員工?
截至 April 01, 2026,公司共有 663 名員工。
Cytek BioSciences 位於哪個產業?
Cytek BioSciences從事於Health Care產業。
Cytek BioSciences 何時完成拆股?
Cytek BioSciences 最近沒有進行任何拆股。
Cytek BioSciences 的總部在哪裡?
Cytek BioSciences 的總部位於 US 的 Fremont。